Gynuity Health Projects

Resources

Resources by Author

Author Selected: Winikoff, Beverly (see all authors)

Misoprostol and Teratogenicity: Reviewing the Evidence

Misoprostol for Women’s Health

Mifepristone medical abortion in Albania

Regimens of misoprostol with mifepristone for early medical abortion

Early pregnancy termination

Clostridium sordellii infection in medical abortion

Misoprostol for uterine evacuation in induced abortion and pregnancy failure

Are two doses of misoprostol after mifepristone for early abortion better than one?

Alternatives to mifepristone for early medical abortion

Mifepristone for late first trimester abortion

Can mifepristone medical abortion be simplified?

Methotrexate compared to misoprostol alone for early medical abortion

Assessment of pregnancy duration among termination of pregnancy clients in South Africa

Abortion is for women

The supreme court and the partial-birth abortion ban act of 2003

Misoprostol for incomplete abortion in Mozambique

Misoprostol for incomplete abortion in Tanzania

Misoprostol for incomplete abortion in Burkina Faso

Treatment of postpartum hemorrhage with misoprostol

Prevention of postpartum hemorrhage with misoprostol

Treatment of incomplete abortion and miscarriage with misoprostol

Misoprostol to treat missed abortion in the first trimester

Supervision for use of mifepristone medical abortion

Integrating medical abortion into safe abortion services in South Africa

Comment on Misoprostol impairs female reproductive tract innate immunity against C. sordellii

Two distinct oral routes of misoprostol in mifepristone medical abortion

Sublingual misoprostol after mifepristone

Non-physician clinicians can safely provide first trimester medical abortion

Sublingual misoprostol for incomplete abortion

Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone

Increasing women’s choices in medical abortion in Turkey

Knowledge, attitudes, and practice of abortion among women and doctors in Armenia

Acceptability and feasibility of medical abortion in Nepal

Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2

Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2

Alternatives to Routine Follow-Up for Early Medical Abortion

High fever following postpartum administration of sublingual misoprostol

What measured blood loss tells us about postpartum bleeding

Misoprostol as adjunct treatment for treatment of postpartum haemorrhage

Unsafe Abortion and Strategies to Reduce its Impact on Women’s Lives

Sublingual misoprostol vs. MVA for the treatment of incomplete abortion in Egypt

Self-induction of abortion among women in the United States

Buccal vs. sublingual misoprostol after mifepristone for medical abortion

Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana

Ultrasound for eligibility assessment for medical abortion

Introduction and provision of medical abortion: A tale of two countries

Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone

Review of the Literature on Patient Satisfaction with Early Medical Abortion

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion

Treatment approaches for preeclampsia in low-resource settings

Oral Misoprostol for the Management of Incomplete Abortion in Ecuador

Facility and personnel factors influencing magnesium sulfate use for eclampsia and pre-eclampsia

Misoprostol for postpartum hemorrhage: Moving from evidence to practice

Two doses of buccal misoprostol following mifepristone

Misoprostol for the prevention and treatment of postpartum hemorrhage